Peptide record

TPDB06926

Antibacterial Antiviral Hemolysis Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06926
Antibacterial Antiviral Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AI4AVP dbAMP 3.0 DRAVP 2.0 HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 13-aa standard-residue multi-activity (Antibacterial, Antiviral, Hemolysis, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FIKRIARLLRKIF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C81H140N24O14
NDCEQGHMPSTWYV
RI
1674.15
12.71
5
0
8
+5
1.81
0.554
157.69
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
0
Residue Composition
number
1
A
3
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
3
I
2
L
2
K
0
M
2
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 3 L: 2 K: 2 M: 0 F: 2 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
13 reviewed residue count
C81H140N24O14 sequence-only estimate (linear, free termini)
1674.15 sequence-only estimate (linear, free termini)
12.71 sequence-only estimate (linear, free termini)
+5 sequence-only estimate (linear, free termini)
1.81 sequence-only estimate (linear, free termini)
0.554 sequence-only estimate (linear, free termini)
Evidence Records 23 records
Evidence 1 Activity

Activity

MIC
Antibacterial
6.25-25 µg/mL

Target

Escherichia coli AB94012 or ATCC 25922

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against Gram- E. coli AB94012 or ATCC 25922 (MIC 6.25-25 ug/ml), P. aeruginosa AB93066 or A092994 like 5 strains (MIC 25-100 ug/ml), Gram+ S. aureus AB94
Evidence 2 Activity

Activity

MIC
Antibacterial
25-100 µg/mL

Target

Pseudomonas aeruginosa AB93066 or A092994 like

Source & Reference

dbAMP DRAMP

Other

active against Gram- E. coli AB94012 or ATCC 25922 (MIC 6.25-25 ug/ml), P. aeruginosa AB93066 or A092994 like 5 strains (MIC 25-100 ug/ml), Gram+ S. aureus AB94004 or ATCC 25923 or MRSA (MIC 3.13 ug/ml), S. epidermidis (MIC 2.5-
Evidence 3 Activity

Activity

MIC
Antibacterial
3.13 µg/mL

Target

Staphylococcus aureus AB94004 or ATCC 25923 or MRSA

Source & Reference

dbAMP DRAMP

Other

6.25-25 ug/ml), P. aeruginosa AB93066 or A092994 like 5 strains (MIC 25-100 ug/ml), Gram+ S. aureus AB94004 or ATCC 25923 or MRSA (MIC 3.13 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/m
Evidence 4 Activity

Activity

MIC
Antibacterial
2.5-5.0 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP

Other

rains (MIC 25-100 ug/ml), Gram+ S. aureus AB94004 or ATCC 25923 or MRSA (MIC 3.13 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/ml), B. subtilis AB91021 (MIC 6.25 ug
Evidence 5 Activity

Activity

MIC
Antibacterial
5-10 µg/mL

Target

Enterococcus faecalis

Source & Reference

dbAMP DRAMP

Other

ureus AB94004 or ATCC 25923 or MRSA (MIC 3.13 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/ml), B. subtilis AB91021 (MIC 6.25 ug/ml), B. thuringiensis AB92037
Evidence 6 Activity

Activity

MIC
Antibacterial
5 µg/mL

Target

E. faecium

Source & Reference

dbAMP DRAMP

Other

MRSA (MIC 3.13 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/ml), B. subtilis AB91021 (MIC 6.25 ug/ml), B. thuringiensis AB92037 (MIC 6.25 ug/ml), and M.
Evidence 7 Activity

Activity

MIC
Antibacterial
6.25 µg/mL

Target

B. subtilis AB91021

Source & Reference

dbAMP DRAMP

Other

epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/ml), B. subtilis AB91021 (MIC 6.25 ug/ml), B. thuringiensis AB92037 (MIC 6.25 ug/ml), and M. luteus AB93113 (MIC 6.25 ug/ml).
Evidence 8 Activity

Activity

MIC
Antibacterial
6.25 µg/mL

Target

B. thuringiensis AB92037

Source & Reference

dbAMP DRAMP

Other

aecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/ml), B. subtilis AB91021 (MIC 6.25 ug/ml), B. thuringiensis AB92037 (MIC 6.25 ug/ml), and M. luteus AB93113 (MIC 6.25 ug/ml).
Evidence 9 Activity

Activity

MIC
Antibacterial
6.25 µg/mL

Target

M. luteus AB93113

Source & Reference

dbAMP DRAMP

Other

ml), B. subtilis AB91021 (MIC 6.25 ug/ml), B. thuringiensis AB92037 (MIC 6.25 ug/ml), and M. luteus AB93113 (MIC 6.25 ug/ml).
Evidence 10 Activity

Activity

MIC
Antiviral
6.25-25 µg/mL

Target

Escherichia coli AB94012 or ATCC 25922

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
active against Gram- E. coli AB94012 or ATCC 25922 (MIC 6.25-25 ug/ml), P. aeruginosa AB93066 or A092994 like 5 strains (MIC 25-100 ug/ml), Gram+ S. aureus AB94
Evidence 11 Activity

Activity

MIC
Antiviral
25-100 µg/mL

Target

Pseudomonas aeruginosa AB93066 or A092994 like

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

active against Gram- E. coli AB94012 or ATCC 25922 (MIC 6.25-25 ug/ml), P. aeruginosa AB93066 or A092994 like 5 strains (MIC 25-100 ug/ml), Gram+ S. aureus AB94004 or ATCC 25923 or MRSA (MIC 3.13 ug/ml), S. epidermidis (MIC 2.5-
Evidence 12 Activity

Activity

MIC
Antiviral
3.13 µg/mL

Target

Staphylococcus aureus AB94004 or ATCC 25923 or MRSA

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

6.25-25 ug/ml), P. aeruginosa AB93066 or A092994 like 5 strains (MIC 25-100 ug/ml), Gram+ S. aureus AB94004 or ATCC 25923 or MRSA (MIC 3.13 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/m
Evidence 13 Activity

Activity

MIC
Antiviral
2.5-5.0 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

rains (MIC 25-100 ug/ml), Gram+ S. aureus AB94004 or ATCC 25923 or MRSA (MIC 3.13 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/ml), B. subtilis AB91021 (MIC 6.25 ug
Evidence 14 Activity

Activity

MIC
Antiviral
5-10 µg/mL

Target

Enterococcus faecalis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ureus AB94004 or ATCC 25923 or MRSA (MIC 3.13 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/ml), B. subtilis AB91021 (MIC 6.25 ug/ml), B. thuringiensis AB92037
Evidence 15 Activity

Activity

MIC
Antiviral
5 µg/mL

Target

E. faecium

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

MRSA (MIC 3.13 ug/ml), S. epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/ml), B. subtilis AB91021 (MIC 6.25 ug/ml), B. thuringiensis AB92037 (MIC 6.25 ug/ml), and M.
Evidence 16 Activity

Activity

MIC
Antiviral
6.25 µg/mL

Target

B. subtilis AB91021

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

epidermidis (MIC 2.5-5.0 ug/ml), E. faecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/ml), B. subtilis AB91021 (MIC 6.25 ug/ml), B. thuringiensis AB92037 (MIC 6.25 ug/ml), and M. luteus AB93113 (MIC 6.25 ug/ml).
Evidence 17 Activity

Activity

MIC
Antiviral
6.25 µg/mL

Target

B. thuringiensis AB92037

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

aecalis (MIC 5-10 ug/ml), E. faecium (MIC 5 ug/ml), B. subtilis AB91021 (MIC 6.25 ug/ml), B. thuringiensis AB92037 (MIC 6.25 ug/ml), and M. luteus AB93113 (MIC 6.25 ug/ml).
Evidence 18 Activity

Activity

MIC
Antiviral
6.25 µg/mL

Target

M. luteus AB93113

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ml), B. subtilis AB91021 (MIC 6.25 ug/ml), B. thuringiensis AB92037 (MIC 6.25 ug/ml), and M. luteus AB93113 (MIC 6.25 ug/ml).
Evidence 19 Activity

Activity

50% Hemolysis
Toxicity
90.27 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | 90.27 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo. | PLoS One | 2012
Evidence 20 Activity

Activity

6.9% Hemolysis
Toxicity
25 µg/mL
Hemolytic Cytotoxic
6.9% Hemolysis | 25 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Fine-Tuning of Alkaline Residues on the Hydrophilic Face Provides a Non-toxic Cationic α-Helical Antimicrobial Peptide Against Antibiotic-Resistant ESKAPE Pathogens. | Front Microbiol | 2021
Evidence 21 Activity

Activity

41% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
41% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Fine-Tuning of Alkaline Residues on the Hydrophilic Face Provides a Non-toxic Cationic α-Helical Antimicrobial Peptide Against Antibiotic-Resistant ESKAPE Pathogens. | Front Microbiol | 2021
Evidence 22 Activity

Activity

% Hemolysis
Toxicity
5 %
Hemolytic
Hemolytic_activity: [Ref.22792229]Non-hemolysis at 6.25 µg/ml, 5% hemolysis at 12.5 µg/ml,10% hemolysis at 25 µg/ml 15% hemolysis at 50 µg/ml, 40% hemolysis at 100 µg/ml against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
PLoS One. 2012 7(7):e40135. doi: 10.1371/journal.pone.0040135.
Evidence 23 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis